Retracted: The Tactical Strategy, Readiness, Epidemiology and Reaction to Potential Treatments for the Possibly Lethal Ebola Virus: A Review
Kaneez Fatima
Department of Biological and Life Sciences, Galgotias University, Greater Noida-203201, India.
Ritika Panwar
Department of Biotechnology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Varnika
Department of Biotechnology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Prachi Saini
Department of Biotechnology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Sudhanshu
Department of Biotechnology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Rashi Bhargava
Department of Mathematics, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Kanchan Bhardwaj
Department of Botany, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Arushi Semwal
Department of Biotechnology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Ayushi Semwal
Department of Biotechnology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Shahana Jabi
Department of Mathematics, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Veena Maurya
Department of Zoology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Rashmi Verma *
Department of Biotechnology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
Naveen Gaurav *
Department of Biotechnology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun-248001, India.
*Author to whom correspondence should be addressed.
Abstract
Over the preceding 38 years, a few outbreaks have been brought on by the Ebola virus, which produces the Ebola illness. No specific treatment has been approved for EVD. Problem management and supportive care are the cornerstones of treatment. Effective outbreak control requires a multidisciplinary team effort that includes case care, infection prevention and control protocols, contact tracing and surveillance, a high-quality laboratory service, dignified and safe funerals, and social and community mobilization. The 2014 Ebola outbreak started in Africa and swiftly spread to other continents before turning into a pandemic. The illness gained international interest because to its relatively peculiar design, lethality and contagiousness, difficulty in containing its spread, and absence of a reliable treatment. Two medications have received FDA approval to treat EVD. Ebanga is a single monoclonal antibody, whereas Inmazeb is a mixture of three monoclonal antibodies. Individuals utilizing any of the two FDA-approved treatments had a significantly greater overall survival rate. In this article, the known history of the Ebola virus, its mode of infection, epidemiology, lifecycle, and possible treatments are briefly reviewed.
This paper has been retracted.